COMMUNIQUÉS West-GlobeNewswire

Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update
19/08/2026
REYKJAVIK, Iceland, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar [...]
Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update
19/08/2026
REYKJAVIK, ICELAND (August 19, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients [...]
Solésence Reports Second Quarter 2026 Financial Results
19/08/2026
Quarterly Report Filed on Form 10-Q Company to Host Conference Call at 5:00 p.m. ET Today ROMEOVILLE, Ill., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically driven health care [...]
Ultragenyx Announces U.S. FDA Approval of GENGLYCOS™ Gene Therapy, the First-Ever FDA-Approved Treatment Designed to Treat the Underlying Cause of Glycogen Storage Disease Type Ia (GSDIa)
19/08/2026
GENGLYCOS is the first gene therapy approval, and fifth FDA approval overall, for the company Approval provides a long-awaited first-ever option to reduce the burden of care associated with GSDIa Ultragenyx received a [...]
Picard Medical Reports Second Quarter 2026 Financial Results
19/08/2026
- Revenue Increases 39% and Net Loss Decreases 16%- Year-to-Date Revenue Increases 50%, with ~$0.9 Million in Gross Profit TUCSON, Ariz., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“ [...]
H1 2026: Novonesis delivered strong 8% organic sales growth and increases full-year outlook
19/08/2026
COPENHAGEN, Denmark – August 19, 2026. Novonesis delivered strong first half of 2026 at 8% organic sales growth. 2026 outlook: Organic sales growth increased to 7-8% (previously 5-7%), and the adjusted EBITDA margin [...]
Interim Report Q2 2026: Successful reception of Evolve3 headsets and gross margin improvement boding well for strong H2 2026
19/08/2026
Highlights The Enterprise division delivered organic revenue growth of -7%, while the organic revenue growth excl. FalCom ended at -3%. The development reflects continued strong growth in North America and APAC. The [...]
Pasatru™ (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions and Clinician-Assessed Flare-ups in a Placebo-controlled Trial in Adults with Fibrodysplasia Ossificans Progressiva (FOP)
19/08/2026
FOP is an ultra-rare genetic disorder characterized by rogue bone formation that infiltrates muscles, tendons, ligaments and other connective tissues, resulting in significant disability Approval based on results from [...]
What Clinicians Evaluate Before Prescribing Low Dose Naltrexone Online
19/08/2026
Provn connects adults 18 and older with independent, U.S.-licensed clinicians who determine whether compounded low-dose naltrexone is medically appropriate. If prescribed, the strength, titration schedule, and [...]
Southern Sky Brands Announces Three New Vape Products in Collaboration with Martin’s in Jackson, Mississippi, Portions of Proceeds to Benefit Veterans Charity
19/08/2026
CANTON, Miss., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Southern Sky Brands is proud to announce the launch of three new vape products created in collaboration with Martin’s, the legendary Mississippi destination known for [...]
Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026
19/08/2026
Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026 Presentation will provide additional analysis from the Phase IIa study of RESP-X in Pseudomonas aeruginosa -colonised [...]
Nasus Pharma Announces Transition of Chief Financial Officer
19/08/2026
TEL AVIV, Israel, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE American: NSRX) ("Nasus", “Nasus Pharma” or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative [...]
Kynexis Extends Series A to €97 Million to Advance Potential First-in-Class Investigational Medicine for Cognitive Disorders
19/08/2026
Novartis Venture Fund joins Kynexis’ existing investor syndicate, supporting the Company’s vision of becoming a leading late-stage cognition company Financing supports Phase 2 close-out activities and preparation for [...]
Grey Matters Retains Nationally Recognized ProScan to Read Brain Images from its Flagship NovaScan Neuroimaging Clinics™ Location in Florida
19/08/2026
VANCOUVER, British Columbia, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “ Company” or “ Grey Matters ”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to [...]
Lungpacer Medical Nominated for 2026 Prix Galien USA Award for Best Medical Technology
19/08/2026
Nomination by the Prix Galien Foundation recognizes the AeroPace® System, the first FDA-approved diaphragm neurostimulation therapy to help critically ill patients breathe on their own again EXTON, Pa., Aug. 19, 2026 ( [...]
TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease
19/08/2026
MENLO PARK, Calif., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative interventional technologies intended to [...]
Avicanna Announces Closing of Strategic Non-Brokered Private Placement
19/08/2026
Strategic investment by pharmaceutical executive and life sciences investor Michael Porter TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a [...]
SK pharmteco célèbre l’avancement des travaux par une cérémonie d’inauguration de deux sites de production de pointe sur son campus de Swords, en Irlande
19/08/2026
L’événement souligne une importante augmentation de la capacité de production commerciale d’API de petites molécules et l’ouverture d’une nouvelle unité de production à l’échelle du kilogramme, conforme aux BPF, dédiée [...]
Applied Biologics Welcomes CMS’ Continued Commitment to Clinical Evidence in Advanced Wound Care
19/08/2026
Applied Biologics believes continued investment in high-quality clinical research is essential to advancing patient care SCOTTSDALE, Ariz., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical [...]

Pages